Beta Bionics Consensus Price Target Raised 14.64% to $23.75

Published 02 Oct 2026, 02:14 UTC. Updated 02 Oct 2026, 05:41 UTC.

The average one-year price target for Beta Bionics (NASDAQGM:BBNX) has been revised to $23.75 / share. This is an increase of 14.64% from the prior estimate of $20.72 dated September 11, 2026. These figures represent aggregate analyst targets compiled from multiple sources and d

Directly affected

BBNX Beta Bionics
Named in this report.

Indirectly affected

SPHB INVESCO S&P 500 HIGH BETA ETF
GA selected SPHB as a RELATED security because its canonical security name directly matches this event's themes: beta. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
BTCZ T-Rex 2X Inverse Bitcoin Daily Target ETF
GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
DOGG FT VEST DJIA DOGS 10 TARGET INCOME ETF
GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
FGSI FT VEST GROWTH STRENGTH & TARGET INCOME ETF
GA selected FGSI as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
ITDB ISHARES LIFEPATH TARGET DATE 2030 ETF
GA selected ITDB as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
ITDC ISHARES LIFEPATH TARGET DATE 2035 ETF USD
GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.

Price reaction, T-5 to T+3

Ticker	T-5	T-3	T-1	T0	T+1	T+2	T+3
BBNX	—	—	—	—	—	—	—
SPHB	—	—	—	—	—	—	—
BTCZ	—	—	—	—	—	—	—
DOGG	—	—	—	—	—	—	—
FGSI	—	—	—	—	—	—	—
ITDB	—	—	—	—	—	—	—
ITDC	—	—	—	—	—	—	—

The average one-year price target for Beta Bionics (NASDAQGM:BBNX) has been revised to $23.75 / share. This is an increase of 14.64% from the prior estimate of $20.72 dated September 11, 2026. These figures represent aggregate analyst targ…

Source: Nasdaq Markets

Beta Bionics (BBNX) since “Beta Bionics Consensus Price Target Raised 14.64% to $23.75,” compared with the market

Since the first closing price after “Beta Bionics Consensus Price Target Raised 14.64% to $23.75,” Beta Bionics (BBNX) is -10.89%. The S&P 500 fund (SPY) is -1.08% over the same days, a -9.81% difference versus the market.

BBNX

SPY

Who is named in “Beta Bionics Consensus Price Target Raised 14.64% to $23.75”

Companies mentioned with this story

BBNX Beta Bionics
Beta Bionics (BBNX) is linked, with no stored direction, high confidence in the 2 Oct 2026 story “Beta Bionics Consensus Price Target Raised 14.64% to $23.75.” Reason on file: The reported development directly names BETA BIONICS INC in the headline; GA resolved that company to BBNX
SPHB Invesco S&P 500 High Beta Etf
In “Beta Bionics Consensus Price Target Raised 14.64% to $23.75,” Invesco S&P 500 High Beta Etf (SPHB) is linked, with no stored direction, medium confidence. Reason on file: GA selected SPHB as a RELATED security because its canonical security name directly matches this event's themes: beta. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
BTCZ T-Rex 2X Inverse Bitcoin Daily Target ETF
For “Beta Bionics Consensus Price Target Raised 14.64% to $23.75,” T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ) is linked, with no stored direction, medium confidence. Reason on file: GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
DOGG Ft Vest Djia Dogs 10 Target Income Etf
For “Beta Bionics Consensus Price Target Raised 14.64% to $23.75,” Ft Vest Djia Dogs 10 Target Income Etf (DOGG) is linked, with no stored direction, medium confidence. Reason on file: GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
FGSI Ft Vest Growth Strength & Target Income Etf
Ft Vest Growth Strength & Target Income Etf (FGSI) is linked, with no stored direction, medium confidence in the 2 Oct 2026 story “Beta Bionics Consensus Price Target Raised 14.64% to $23.75.” Reason on file: GA selected FGSI as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
ITDB Ishares Lifepath Target Date 2030 Etf
In “Beta Bionics Consensus Price Target Raised 14.64% to $23.75,” Ishares Lifepath Target Date 2030 Etf (ITDB) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDB as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
ITDC Ishares Lifepath Target Date 2035 Etf Usd
For “Beta Bionics Consensus Price Target Raised 14.64% to $23.75,” Ishares Lifepath Target Date 2035 Etf Usd (ITDC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article

How “Beta Bionics Consensus Price Target Raised 14.64% to $23.75” reaches Beta Bionics (BBNX)

On 2 Oct 2026, “Beta Bionics Consensus Price Target Raised 14.64% to $23.75” is the story that connects Beta Bionics (BBNX) to this story.

The link for Beta Bionics (BBNX) is this: The reported development directly names BETA BIONICS INC in the headline; GA resolved that company to BBNX

Invesco S&P 500 High Beta Etf (SPHB) is here too. Its reason reads: GA selected SPHB as a RELATED security because its canonical security name directly matches this event's themes: beta. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article

Price levels for Beta Bionics (BBNX)

BBNX traded between 16.32 and 23.56 across 20 sessions. The latest close on file is 16.85. BTCZ traded between 2.69 and 3.21 across 20 sessions. The latest close on file is 3.06. SPHB traded between 138.69 and 157.54 across 20 sessions. The latest close on file is 140.56.

How solid “Beta Bionics Consensus Price Target Raised 14.64% to $23.75” looks

46 out of 100

“Beta Bionics Consensus Price Target Raised 14.64% to $23.75” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.